ราคาของ Coya Therapeutics, Inc. (COYA) คืออะไร

ราคาของ Coya Therapeutics, Inc. (COYA) คือ $4.83

หมวกตลาดของ Coya Therapeutics, Inc. คืออะไร (COYA)

ฝาครอบตลาดของ Coya Therapeutics, Inc. (COYA) คือ $113.30M

ประวัติราคาของ Coya Therapeutics, Inc. (COYA)

Coya Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapeutic agents that fine-tune the function of regulatory T cells (Tregs). Its therapeutic pipeline leverages diverse approaches, including biologics designed to enhance Treg activity, Treg-derived exosomes, and personalized autologous Treg cell therapies. Among its lead candidates is COYA 101, an autologous regulatory T-cell product that has successfully completed Phase 2a clinical trials for treating Amyotrophic Lateral Sclerosis (ALS). Moving towards Investigational New Drug (IND) applications are two key candidates: COYA 301 and COYA 302. COYA 301 is a Treg-enhancing biologic aimed at treating Frontotemporal Dementia. Meanwhile, COYA 302 is a dual-action biologic combination, suitable for subcutaneous or intravenous delivery, engineered to not only boost Treg function but also to diminish harmful T effector cell activity and activated macrophages in neurodegenerative and autoimmune disorders. Additionally, Coya has earlier-stage programs, including COYA 201, an allogeneic (off-the-shelf) Treg exosome candidate in preclinical development for a range of neurodegenerative, autoimmune, and metabolic conditions. Its pipeline also features COYA 206, an antigen-directed Treg-derived exosome product, currently in the discovery phase. Established in 2020, Coya Therapeutics maintains its headquarters in Houston, Texas.

ปี	ประสิทธิภาพ
2026 (TTM)	-10.79%
2025	0.58%
2024	-19.02%
2023	53.38%
2022	0.00%

ปี

ประสิทธิภาพ

2026 (TTM)

-10.79%

2025

0.58%

2024

-19.02%

2023

53.38%

2022

0.00%

บริษัท	ราคาหุ้น	การเปลี่ยนแปลง 1ปี%	ประเทศ
Vertex Pharmaceuticals Incorporated VRTX.US	$547.71	38.62%	US
Argenx SE ARGX.US	$1.04K	58.06%	NL
Moderna, Inc. MRNA.US	$145.75	437.43%	US
CSL Limited CSL.AX	$118.70	-15.60%	AU
Lonza Group AG LONN.SW	$770.19	8.98%	CH

บริษัท

ราคาหุ้น

การเปลี่ยนแปลง 1ปี%

ประเทศ